Abstract
Activities of mitochondrial enzymes in blood cells from 69 patients with primary sideroblastic anemia were determined to elucidate the pathogenesis of the disease. In erythroblasts of patients with primary acquired type the activities of both δ-aminolevulinic acid synthetase and mitochondrial serine protease were inevitably decreased. The susceptibility to the protease of apo-δ-aminolevulinic acid synthetase prepared from erythroblasts of patients with this type was within the normal range, in contrast to that of pyridoxine-responsive anemia. The activities of mitochondrial enzymes such as cytochrome oxidase, serine protease, and oligomycin-sensitive ATPase, except citrate synthetase, were usually decreased in mature granulocytes of the patients. Patients with hereditary sideroblastic anemia also had decreased δ-aminolevulinic acid synthetase activity in erythroblasts, and decreased serine protease activity in both erythroblasts and mature granulocytes. Mature granulocytes obtained from patients with pyridoxine-responsive anemia before therapy had decreased cytochrome oxidase activity, however, the activity increased to a normal level when the patients were in remission. The activities of other mitochondrial enzymes in mature granulocytes were within normal range in these patients before pyridoxine therapy. The activities of these mitochondrial enzymes in lymphocytes were within normal range in all groups of patients with primary sideroblastic anemia.
We suggest that patients with primary acquired, and possibly also those with hereditary sideroblastic anemia have impaired mitochondrial function in both erythroblasts and granulocytes. That only anemia is observed in these patients is because a functional abnormality of mitochondria in erythroblasts is most important because of the role of mitochondria in the formation of heme in erythrocyte development. In contrast to these two types of sideroblastic anemia, only δ-aminolevulinic acid synthetase in both erythroblasts and granulocytes seems to be impaired in patients with pyridoxine-responsive anemia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aoki Y. Crystallization and characterization of a new protease in mitochondria of bone marrow cells. J Biol Chem. 1978 Mar 25;253(6):2026–2032. [PubMed] [Google Scholar]
- Aoki Y., Muranaka S., Nakabayashi K., Ueda Y. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. J Clin Invest. 1979 Nov;64(5):1196–1203. doi: 10.1172/JCI109573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aoki Y., Urata G., Wada O., Takaku F. Measurement of delta-aminolevulinic acid synthetase activity in human erythroblasts. J Clin Invest. 1974 May;53(5):1326–1334. doi: 10.1172/JCI107680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BARRY W. E., DAY H. J. REFRACTORY SIDEROBLASTIC ANEMIA. CLINICAL AND HEMATOLOGIC STUDY OF TEN CASES. Ann Intern Med. 1964 Dec;61:1029–1044. doi: 10.7326/0003-4819-61-6-1029. [DOI] [PubMed] [Google Scholar]
- Cartwright G. E., Deiss A. Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J Med. 1975 Jan 23;292(4):185–193. doi: 10.1056/NEJM197501232920405. [DOI] [PubMed] [Google Scholar]
- Kushner J. P., Lee G. R., Wintrobe M. M., Cartwright G. E. Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature. Medicine (Baltimore) 1971 May;50(3):139–159. doi: 10.1097/00005792-197105000-00001. [DOI] [PubMed] [Google Scholar]
- SBARRA A. J., KARNOVSKY M. L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959 Jun;234(6):1355–1362. [PubMed] [Google Scholar]
- Umezawa H., Aoyagi T., Okura A., Morishima H., Takeuchi T. Letter: Elastatinal, a new elastase inhibitor produced by actinomycetes. J Antibiot (Tokyo) 1973 Dec;26(12):787–789. doi: 10.7164/antibiotics.26.787. [DOI] [PubMed] [Google Scholar]
- Vavra J. D., Poff S. A. Heme and prophyrin synthesis in sideroblastic anemia. J Lab Clin Med. 1967 Jun;69(6):904–918. [PubMed] [Google Scholar]
- Wickramasinghe S. N., Hughes M. Capacity of ringed sideroblasts to synthesize nucleic acids and protein in patients with primary acquired sideroblastic anaemia. Br J Haematol. 1978 Mar;38(3):345–352. doi: 10.1111/j.1365-2141.1978.tb01053.x. [DOI] [PubMed] [Google Scholar]